Insomnia Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Insomnia Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Globalxxxxxxxxxxxx4.2%
North Americaxxxxxxxxxxxxxxxx
Europexxxxxxxxxxxxxxxx
Asia Pacificxxxxxxxxxxxxxxxx
South Americaxxxxxxxxxxxxxxxx
Middle Eastxxxxxxxxxxxxxxxx

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis


Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

May 2023: Researchers found that sleep medications, which are commonly used to treat insomnia or trouble falling and staying asleep, dramatically lower rapid eye movement (REM) sleep behavior disorder. Furthermore, these medications—often referred to as dual orexin receptor antagonists—would have fewer adverse effects, according to the study's findings. (Source: https://www.mountsinai.org/about/newsroom/2023/mount-sinai-researchers-identify-potential-new-treatment-for-those-who-act-out-their-dreams-while-sleeping )

Click any bar or cell to request the full company profile
Top Companies (In no particular order)2022 (A)2023 (A)2024 (A)2025 (A)
MINERVA NEUROSCIENCES INC••• ••• ••• •••
Sanofi••• ••• ••• •••
EISAI••• ••• ••• •••
CO. LTD••• ••• ••• •••
VIATRIS INC••• ••• ••• •••
Vanda Pharmaceuticals Inc.••• ••• ••• •••
Takeda Pharmaceutical Company Ltd••• ••• ••• •••
Merck KGAa••• ••• ••• •••
Darmstadt Germany••• ••• ••• •••
Zydus Cadila••• ••• ••• •••
Pfizer Inc.••• ••• ••• •••
CURRAX PHARMACEUTICALS LLC••• ••• ••• •••
Others••• ••• ••• •••

We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.

Request company profile for validation →

Report Scope & Analysis

According to Cognitive Market Research, the global insomnia market size is USD 5.7 billion in 2024 and will expand at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

Introduction of the Insomnia Market

A sleep problem called insomnia can deplete a person's energy and have an impact on their mood, general well-being, productivity at work, and general quality of life. Stress, extended travel, busy work schedules, irregular sleep patterns, binge eating, and excessive use of alcohol, caffeine, and nicotine are among its frequent causes. It may also be linked to mental health conditions like post-traumatic stress disorder and the use of over-the-counter (OTC) medications for pain, allergies, and colds as well as antidepressants for blood pressure and asthma. Factors supporting the growth of the insomnia therapeutics market include increasing stress levels, patentable compounds in the market, potential medications in the clinical pipeline, the introduction of technologically improved medical devices, and an aging population.

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Insomnia Market Analysis is witnessing significant growth in the near future.

In 2023, the Benzodiazepines segment accounted for a notable share of the Insomnia Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst · Cognitive Market Research
LinkedIn Profile Book a free Consultation

Frequently Asked Questions

Insomnia Market Analysis market size and growth rate is provided in the report covering 2021-2025 historical and 2025-2033 forecast data.
Major factors including drivers, restraints, opportunities and challenges are analyzed with detailed insights.
Top manufacturers MINERVA NEUROSCIENCES INC, Sanofi, EISAI, CO. LTD, VIATRIS INC, Vanda Pharmaceuticals Inc., Takeda Pharmaceutical Company Ltd, Merck KGAa, Darmstadt Germany, Zydus Cadila, Pfizer Inc., CURRAX PHARMACEUTICALS LLC, Others and others are profiled in the report.
Segments include Treatment Type, Sales Channel and additional sub-segments.
Regional analysis covers all major markets. The report identifies the dominant region and provides country-level data.
Sample pages can be obtained on demand from the website. 24/7 chat support and direct call services are available.

★ Reviews

Rate this report

Insomnia Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).
License Edition

Treatment Type Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonist, Melatonin Antagonist, Devices, Others
Sales Channel Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online Pharmacies
List of Competitors MINERVA NEUROSCIENCES INC, Sanofi, EISAI, CO. LTD, VIATRIS INC, Vanda Pharmaceuticals Inc., Takeda Pharmaceutical Company Ltd, Merck KGAa, Darmstadt Germany, Zydus Cadila, Pfizer Inc., CURRAX PHARMACEUTICALS LLC, Others

  • 1.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      1.1.1 Global Insomnia Market Analysis by Key Players
    • 1.1.2 Global Insomnia Market Volume and Share by Key Players
    • 1.1.3 Top Players Ranking 2024
    • 1.1.4 New Product Launch Analysis
    • 1.1.5 Industry Mergers and Acquisition Analysis
  • 1.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.1 MINERVA NEUROSCIENCES INC
      • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.1.2 Business Overview
      • 1.2.1.3 Financials (Subject to data availability)
      • 1.2.1.4 R&D Investment (Subject to data availability)
      • 1.2.1.5 Product Types Specification
      • 1.2.1.6 Business Strategy
      • 1.2.1.7 Recent Developments
      • 1.2.1.8 Management Change
      • 1.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.2 Sanofi
      • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.2.2 Business Overview
      • 1.2.2.3 Financials (Subject to data availability)
      • 1.2.2.4 R&D Investment (Subject to data availability)
      • 1.2.2.5 Product Types Specification
      • 1.2.2.6 Business Strategy
      • 1.2.2.7 Recent Developments
      • 1.2.2.8 Management Change
      • 1.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.3 EISAI
      • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.3.2 Business Overview
      • 1.2.3.3 Financials (Subject to data availability)
      • 1.2.3.4 R&D Investment (Subject to data availability)
      • 1.2.3.5 Product Types Specification
      • 1.2.3.6 Business Strategy
      • 1.2.3.7 Recent Developments
      • 1.2.3.8 Management Change
      • 1.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.4 CO. LTD
      • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.4.2 Business Overview
      • 1.2.4.3 Financials (Subject to data availability)
      • 1.2.4.4 R&D Investment (Subject to data availability)
      • 1.2.4.5 Product Types Specification
      • 1.2.4.6 Business Strategy
      • 1.2.4.7 Recent Developments
      • 1.2.4.8 Management Change
      • 1.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.5 VIATRIS INC
      • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.5.2 Business Overview
      • 1.2.5.3 Financials (Subject to data availability)
      • 1.2.5.4 R&D Investment (Subject to data availability)
      • 1.2.5.5 Product Types Specification
      • 1.2.5.6 Business Strategy
      • 1.2.5.7 Recent Developments
      • 1.2.5.8 Management Change
      • 1.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.6 Vanda Pharmaceuticals Inc.
      • 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.6.2 Business Overview
      • 1.2.6.3 Financials (Subject to data availability)
      • 1.2.6.4 R&D Investment (Subject to data availability)
      • 1.2.6.5 Product Types Specification
      • 1.2.6.6 Business Strategy
      • 1.2.6.7 Recent Developments
      • 1.2.6.8 Management Change
      • 1.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.7 Takeda Pharmaceutical Company Ltd
      • 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.7.2 Business Overview
      • 1.2.7.3 Financials (Subject to data availability)
      • 1.2.7.4 R&D Investment (Subject to data availability)
      • 1.2.7.5 Product Types Specification
      • 1.2.7.6 Business Strategy
      • 1.2.7.7 Recent Developments
      • 1.2.7.8 Management Change
      • 1.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.8 Merck KGAa
      • 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.8.2 Business Overview
      • 1.2.8.3 Financials (Subject to data availability)
      • 1.2.8.4 R&D Investment (Subject to data availability)
      • 1.2.8.5 Product Types Specification
      • 1.2.8.6 Business Strategy
      • 1.2.8.7 Recent Developments
      • 1.2.8.8 Management Change
      • 1.2.8.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.9 Darmstadt Germany
      • 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.9.2 Business Overview
      • 1.2.9.3 Financials (Subject to data availability)
      • 1.2.9.4 R&D Investment (Subject to data availability)
      • 1.2.9.5 Product Types Specification
      • 1.2.9.6 Business Strategy
      • 1.2.9.7 Recent Developments
      • 1.2.9.8 Management Change
      • 1.2.9.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.10 Zydus Cadila
      • 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.10.2 Business Overview
      • 1.2.10.3 Financials (Subject to data availability)
      • 1.2.10.4 R&D Investment (Subject to data availability)
      • 1.2.10.5 Product Types Specification
      • 1.2.10.6 Business Strategy
      • 1.2.10.7 Recent Developments
      • 1.2.10.8 Management Change
      • 1.2.10.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.11 Pfizer Inc.
      • 1.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.11.2 Business Overview
      • 1.2.11.3 Financials (Subject to data availability)
      • 1.2.11.4 R&D Investment (Subject to data availability)
      • 1.2.11.5 Product Types Specification
      • 1.2.11.6 Business Strategy
      • 1.2.11.7 Recent Developments
      • 1.2.11.8 Management Change
      • 1.2.11.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.12 CURRAX PHARMACEUTICALS LLC
      • 1.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.12.2 Business Overview
      • 1.2.12.3 Financials (Subject to data availability)
      • 1.2.12.4 R&D Investment (Subject to data availability)
      • 1.2.12.5 Product Types Specification
      • 1.2.12.6 Business Strategy
      • 1.2.12.7 Recent Developments
      • 1.2.12.8 Management Change
      • 1.2.12.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.13 Others
      • 1.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.13.2 Business Overview
      • 1.2.13.3 Financials (Subject to data availability)
      • 1.2.13.4 R&D Investment (Subject to data availability)
      • 1.2.13.5 Product Types Specification
      • 1.2.13.6 Business Strategy
      • 1.2.13.7 Recent Developments
      • 1.2.13.8 Management Change
      • 1.2.13.9 S.W.O.T Analysis

  • 2.1 Global Insomnia Revenue Market Size, Trend Analysis 2022 - 2034
  • 2.2 Global Insomnia Volume Market Sales, Trend Analysis 2022 - 2034

  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    2.3 Global Insomnia Market Analysis By Regions 2022 - 2034
    • 2.3.1 Global Insomnia Revenue Market Size By Region
    • 2.3.2 Global Insomnia Volume Market Sales By Region
  • 2.4 Global Insomnia Market Size By Treatment Type 2022 - 2034
    • 2.4.1 Benzodiazepines Market Size
    • 2.4.2 Nonbenzodiazepines Market Size
    • 2.4.3 Antidepressants Market Size
    • 2.4.4 Orexin Antagonist Market Size
    • 2.4.5 Melatonin Antagonist Market Size
    • 2.4.6 Devices Market Size
    • 2.4.7 Others Market Size
  • 2.5 Global Insomnia Volume Market Sales By Treatment Type 2022 - 2034
    • 2.5.1 Benzodiazepines Sales Volume
    • 2.5.2 Nonbenzodiazepines Sales Volume
    • 2.5.3 Antidepressants Sales Volume
    • 2.5.4 Orexin Antagonist Sales Volume
    • 2.5.5 Melatonin Antagonist Sales Volume
    • 2.5.6 Devices Sales Volume
    • 2.5.7 Others Sales Volume
  • 2.6 Global Insomnia Market Size By Sales Channel 2022 - 2034
    • 2.6.1 Hospital Pharmacies Market Size
    • 2.6.2 Retail Pharmacies and Drug Stores Market Size
    • 2.6.3 Online Pharmacies Market Size
  • 2.7 Global Insomnia Volume Market Sales By Sales Channel 2022 - 2034
    • 2.7.1 Hospital Pharmacies Sales Volume
    • 2.7.2 Retail Pharmacies and Drug Stores Sales Volume
    • 2.7.3 Online Pharmacies Sales Volume
  • 2.8 Global Level Competitor Analysis (Subject to Data Availability (Private Players))

  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    2.9 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 2.9.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 2.9.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
    • 2.9.3 Global Market Revenue Split By Treatment Type
    • 2.9.4 Global Volume Market Split By Treatment Type
    • 2.9.5 Global Market Revenue Split By Sales Channel
    • 2.9.6 Global Volume Market Split By Sales Channel

    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      2.9.7 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

  • 3.1 North America Insomnia Market Outlook
    • 3.1.1 North America Insomnia Market Size 2022 - 2034
    • 3.1.2 North America Insomnia Volume Market Sales 2022 - 2034
    • 3.1.3 North America Insomnia Market Size By Country 2022 - 2034
    • 3.1.4 North America Insomnia Volume Market Sales By Country 2022 - 2034
    • 3.1.5 North America Insomnia Market Size by Treatment Type 2022 - 2034
      • 3.1.5.1 North America Benzodiazepines Market Size
      • 3.1.5.2 North America Nonbenzodiazepines Market Size
      • 3.1.5.3 North America Antidepressants Market Size
      • 3.1.5.4 North America Orexin Antagonist Market Size
      • 3.1.5.5 North America Melatonin Antagonist Market Size
      • 3.1.5.6 North America Devices Market Size
      • 3.1.5.7 North America Others Market Size
    • 3.1.6 North America Insomnia Volume Market Sales by Treatment Type 2022 - 2034
      • 3.1.6.1 North America Benzodiazepines Sales Volume
      • 3.1.6.2 North America Nonbenzodiazepines Sales Volume
      • 3.1.6.3 North America Antidepressants Sales Volume
      • 3.1.6.4 North America Orexin Antagonist Sales Volume
      • 3.1.6.5 North America Melatonin Antagonist Sales Volume
      • 3.1.6.6 North America Devices Sales Volume
      • 3.1.6.7 North America Others Sales Volume
    • 3.1.7 North America Insomnia Market Size by Sales Channel 2022 - 2034
      • 3.1.7.1 North America Hospital Pharmacies Market Size
      • 3.1.7.2 North America Retail Pharmacies and Drug Stores Market Size
      • 3.1.7.3 North America Online Pharmacies Market Size
    • 3.1.8 North America Insomnia Volume Market Sales by Sales Channel 2022 - 2034
      • 3.1.8.1 North America Hospital Pharmacies Sales Volume
      • 3.1.8.2 North America Retail Pharmacies and Drug Stores Sales Volume
      • 3.1.8.3 North America Online Pharmacies Sales Volume

  • 4.1 Europe Insomnia Market Outlook
    • 4.1.1 Europe Insomnia Market Size 2022 - 2034
    • 4.1.2 Europe Insomnia Volume Market Sales 2022 - 2034
    • 4.1.3 Europe Insomnia Market Size By Country 2022 - 2034
    • 4.1.4 Europe Insomnia Volume Market Sales By Country 2022 - 2034
    • 4.1.5 Europe Insomnia Market Size by Treatment Type 2022 - 2034
      • 4.1.5.1 Europe Benzodiazepines Market Size
      • 4.1.5.2 Europe Nonbenzodiazepines Market Size
      • 4.1.5.3 Europe Antidepressants Market Size
      • 4.1.5.4 Europe Orexin Antagonist Market Size
      • 4.1.5.5 Europe Melatonin Antagonist Market Size
      • 4.1.5.6 Europe Devices Market Size
      • 4.1.5.7 Europe Others Market Size
    • 4.1.6 Europe Insomnia Volume Market Sales by Treatment Type 2022 - 2034
      • 4.1.6.1 Europe Benzodiazepines Sales Volume
      • 4.1.6.2 Europe Nonbenzodiazepines Sales Volume
      • 4.1.6.3 Europe Antidepressants Sales Volume
      • 4.1.6.4 Europe Orexin Antagonist Sales Volume
      • 4.1.6.5 Europe Melatonin Antagonist Sales Volume
      • 4.1.6.6 Europe Devices Sales Volume
      • 4.1.6.7 Europe Others Sales Volume
    • 4.1.7 Europe Insomnia Market Size by Sales Channel 2022 - 2034
      • 4.1.7.1 Europe Hospital Pharmacies Market Size
      • 4.1.7.2 Europe Retail Pharmacies and Drug Stores Market Size
      • 4.1.7.3 Europe Online Pharmacies Market Size
    • 4.1.8 Europe Insomnia Volume Market Sales by Sales Channel 2022 - 2034
      • 4.1.8.1 Europe Hospital Pharmacies Sales Volume
      • 4.1.8.2 Europe Retail Pharmacies and Drug Stores Sales Volume
      • 4.1.8.3 Europe Online Pharmacies Sales Volume

  • 5.1 Asia Pacific Insomnia Market Outlook
    • 5.1.1 Asia Pacific Insomnia Market Size 2022 - 2034
    • 5.1.2 Asia Pacific Insomnia Volume Market Sales 2022 - 2034
    • 5.1.3 Asia Pacific Insomnia Market Size By Country 2022 - 2034
    • 5.1.4 Asia Pacific Insomnia Volume Market Sales By Country 2022 - 2034
    • 5.1.5 Asia Pacific Insomnia Market Size by Treatment Type 2022 - 2034
      • 5.1.5.1 Asia Pacific Benzodiazepines Market Size
      • 5.1.5.2 Asia Pacific Nonbenzodiazepines Market Size
      • 5.1.5.3 Asia Pacific Antidepressants Market Size
      • 5.1.5.4 Asia Pacific Orexin Antagonist Market Size
      • 5.1.5.5 Asia Pacific Melatonin Antagonist Market Size
      • 5.1.5.6 Asia Pacific Devices Market Size
      • 5.1.5.7 Asia Pacific Others Market Size
    • 5.1.6 Asia Pacific Insomnia Volume Market Sales by Treatment Type 2022 - 2034
      • 5.1.6.1 Asia Pacific Benzodiazepines Sales Volume
      • 5.1.6.2 Asia Pacific Nonbenzodiazepines Sales Volume
      • 5.1.6.3 Asia Pacific Antidepressants Sales Volume
      • 5.1.6.4 Asia Pacific Orexin Antagonist Sales Volume
      • 5.1.6.5 Asia Pacific Melatonin Antagonist Sales Volume
      • 5.1.6.6 Asia Pacific Devices Sales Volume
      • 5.1.6.7 Asia Pacific Others Sales Volume
    • 5.1.7 Asia Pacific Insomnia Market Size by Sales Channel 2022 - 2034
      • 5.1.7.1 Asia Pacific Hospital Pharmacies Market Size
      • 5.1.7.2 Asia Pacific Retail Pharmacies and Drug Stores Market Size
      • 5.1.7.3 Asia Pacific Online Pharmacies Market Size
    • 5.1.8 Asia Pacific Insomnia Volume Market Sales by Sales Channel 2022 - 2034
      • 5.1.8.1 Asia Pacific Hospital Pharmacies Sales Volume
      • 5.1.8.2 Asia Pacific Retail Pharmacies and Drug Stores Sales Volume
      • 5.1.8.3 Asia Pacific Online Pharmacies Sales Volume

  • 6.1 South America Insomnia Market Outlook
    • 6.1.1 South America Insomnia Market Size 2022 - 2034
    • 6.1.2 South America Insomnia Volume Market Sales 2022 - 2034
    • 6.1.3 South America Insomnia Market Size By Country 2022 - 2034
    • 6.1.4 South America Insomnia Volume Market Sales By Country 2022 - 2034
    • 6.1.5 South America Insomnia Market Size by Treatment Type 2022 - 2034
      • 6.1.5.1 South America Benzodiazepines Market Size
      • 6.1.5.2 South America Nonbenzodiazepines Market Size
      • 6.1.5.3 South America Antidepressants Market Size
      • 6.1.5.4 South America Orexin Antagonist Market Size
      • 6.1.5.5 South America Melatonin Antagonist Market Size
      • 6.1.5.6 South America Devices Market Size
      • 6.1.5.7 South America Others Market Size
    • 6.1.6 South America Insomnia Volume Market Sales by Treatment Type 2022 - 2034
      • 6.1.6.1 South America Benzodiazepines Sales Volume
      • 6.1.6.2 South America Nonbenzodiazepines Sales Volume
      • 6.1.6.3 South America Antidepressants Sales Volume
      • 6.1.6.4 South America Orexin Antagonist Sales Volume
      • 6.1.6.5 South America Melatonin Antagonist Sales Volume
      • 6.1.6.6 South America Devices Sales Volume
      • 6.1.6.7 South America Others Sales Volume
    • 6.1.7 South America Insomnia Market Size by Sales Channel 2022 - 2034
      • 6.1.7.1 South America Hospital Pharmacies Market Size
      • 6.1.7.2 South America Retail Pharmacies and Drug Stores Market Size
      • 6.1.7.3 South America Online Pharmacies Market Size
    • 6.1.8 South America Insomnia Volume Market Sales by Sales Channel 2022 - 2034
      • 6.1.8.1 South America Hospital Pharmacies Sales Volume
      • 6.1.8.2 South America Retail Pharmacies and Drug Stores Sales Volume
      • 6.1.8.3 South America Online Pharmacies Sales Volume

  • 7.1 Middle East Insomnia Market Outlook
    • 7.1.1 Middle East Insomnia Market Size 2022 - 2034
    • 7.1.2 Middle East Insomnia Volume Market Sales 2022 - 2034
    • 7.1.3 Middle East Insomnia Market Size By Country 2022 - 2034
    • 7.1.4 Middle East Insomnia Volume Market Sales By Country 2022 - 2034
    • 7.1.5 Middle East Insomnia Market Size by Treatment Type 2022 - 2034
      • 7.1.5.1 Middle East Benzodiazepines Market Size
      • 7.1.5.2 Middle East Nonbenzodiazepines Market Size
      • 7.1.5.3 Middle East Antidepressants Market Size
      • 7.1.5.4 Middle East Orexin Antagonist Market Size
      • 7.1.5.5 Middle East Melatonin Antagonist Market Size
      • 7.1.5.6 Middle East Devices Market Size
      • 7.1.5.7 Middle East Others Market Size
    • 7.1.6 Middle East Insomnia Volume Market Sales by Treatment Type 2022 - 2034
      • 7.1.6.1 Middle East Benzodiazepines Sales Volume
      • 7.1.6.2 Middle East Nonbenzodiazepines Sales Volume
      • 7.1.6.3 Middle East Antidepressants Sales Volume
      • 7.1.6.4 Middle East Orexin Antagonist Sales Volume
      • 7.1.6.5 Middle East Melatonin Antagonist Sales Volume
      • 7.1.6.6 Middle East Devices Sales Volume
      • 7.1.6.7 Middle East Others Sales Volume
    • 7.1.7 Middle East Insomnia Market Size by Sales Channel 2022 - 2034
      • 7.1.7.1 Middle East Hospital Pharmacies Market Size
      • 7.1.7.2 Middle East Retail Pharmacies and Drug Stores Market Size
      • 7.1.7.3 Middle East Online Pharmacies Market Size
    • 7.1.8 Middle East Insomnia Volume Market Sales by Sales Channel 2022 - 2034
      • 7.1.8.1 Middle East Hospital Pharmacies Sales Volume
      • 7.1.8.2 Middle East Retail Pharmacies and Drug Stores Sales Volume
      • 7.1.8.3 Middle East Online Pharmacies Sales Volume

  • 8.1 Africa Insomnia Market Outlook
    • 8.1.1 Africa Insomnia Market Size 2022 - 2034
    • 8.1.2 Africa Insomnia Volume Market Sales 2022 - 2034
    • 8.1.3 Africa Insomnia Market Size By Country 2022 - 2034
    • 8.1.4 Africa Insomnia Volume Market Sales By Country 2022 - 2034
    • 8.1.5 Africa Insomnia Market Size by Treatment Type 2022 - 2034
      • 8.1.5.1 Africa Benzodiazepines Market Size
      • 8.1.5.2 Africa Nonbenzodiazepines Market Size
      • 8.1.5.3 Africa Antidepressants Market Size
      • 8.1.5.4 Africa Orexin Antagonist Market Size
      • 8.1.5.5 Africa Melatonin Antagonist Market Size
      • 8.1.5.6 Africa Devices Market Size
      • 8.1.5.7 Africa Others Market Size
    • 8.1.6 Africa Insomnia Volume Market Sales by Treatment Type 2022 - 2034
      • 8.1.6.1 Africa Benzodiazepines Sales Volume
      • 8.1.6.2 Africa Nonbenzodiazepines Sales Volume
      • 8.1.6.3 Africa Antidepressants Sales Volume
      • 8.1.6.4 Africa Orexin Antagonist Sales Volume
      • 8.1.6.5 Africa Melatonin Antagonist Sales Volume
      • 8.1.6.6 Africa Devices Sales Volume
      • 8.1.6.7 Africa Others Sales Volume
    • 8.1.7 Africa Insomnia Market Size by Sales Channel 2022 - 2034
      • 8.1.7.1 Africa Hospital Pharmacies Market Size
      • 8.1.7.2 Africa Retail Pharmacies and Drug Stores Market Size
      • 8.1.7.3 Africa Online Pharmacies Market Size
    • 8.1.8 Africa Insomnia Volume Market Sales by Sales Channel 2022 - 2034
      • 8.1.8.1 Africa Hospital Pharmacies Sales Volume
      • 8.1.8.2 Africa Retail Pharmacies and Drug Stores Sales Volume
      • 8.1.8.3 Africa Online Pharmacies Sales Volume

  • 9.1 Market Drivers
  • 9.2 Market Restraints
  • 9.3 Market Trends
  • 9.4 Market Opportunity
  • 9.5 Technological Road Map (Subject to Data Availability)
  • 9.6 Product Life Cycle (Subject to Data Availability)
  • 9.7 Customer and Buyer Behavior Analysis
    • 9.7.1 Consumer Demographics and Target Audience Assessment
    • 9.7.2 Consumer Purchase Behavior and Demand Assessment
    • 9.7.3 Consumer Pricing Dynamics and Affordability Assessment
    • 9.7.4 Digital Engagement, Customer Experience & Relationship Analysis
    • 9.7.5 Future Consumption Trends and Demand Evolution Analysis
    • 9.7.6 Enterprise Procurement & Purchasing Behavior Analysis
    • 9.7.7 Customer Buying Behavior & Purchase Decision Analysis
    • 9.7.8 Customer Expectations & Service Experience Evaluation
    • 9.7.9 Vendor Selection, Supplier Preferences & Future Demand Trends
    • 9.7.10 Customer Retention & Loyalty Strategy Assessment
    • 9.7.11 Pricing, Affordability & Value Perception Analysis
    • 9.7.12 Customer Segmentation & Demand Pattern Analysis
    • 9.7.13 Relationship Management & Strategic Partnership Trends
  • 9.8 Market Attractiveness Analysis
  • 9.9 PESTEL Analysis
    • 9.9.1 Political Factors
    • 9.9.2 Economic Factors
    • 9.9.3 Social Factors
    • 9.9.4 Technological Factors
    • 9.9.5 Legal Factors
    • 9.9.6 Environmental Factors
  • 9.10 Industrial Chain Analysis (Subject to Data Availability)
    • 9.10.1 Industry Chain Analysis
    • 9.10.2 Manufacturing Cost Analysis
    • 9.10.3 Supply Side Analysis
      • 9.10.3.1 Raw Material Analysis
      • 9.10.3.2 Raw Material Procurement Analysis
      • 9.10.3.3 Raw Material Price Trend Analysis
  • 9.11 Porter’s Five Forces Analysis
    • 9.11.1 Bargaining Power of Suppliers
    • 9.11.2 Bargaining Power of Buyers
    • 9.11.3 Threat of New Entrants
    • 9.11.4 Threat of Substitutes
    • 9.11.5 Degree of Competition
  • 9.12 Patent Analysis (Subject to Data Availability)
  • 9.13 ESG Analysis
  • 9.14 Geopolitical Outlook
    • 9.14.1 Global Power Realignment & Strategic Alliances
    • 9.14.2 Geopolitical Risk Landscape & Conflict Hotspots
    • 9.14.3 International Trade Relations & Market Access Environment
    • 9.14.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
    • 9.14.5 Supply Chain Resilience, Localization & Resource Nationalism
    • 9.14.6 Technology Sovereignty & Digital Geopolitics
    • 9.14.7 Strategic Implications for Investment, Growth & Market Entry

  • This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy

    9.15 AI & Market Transformation
    • 9.15.1 Competitive Landscape Disruption & Strategic Shifts
    • 9.15.2 AI-Driven Transformation of Industry Value Chain
    • 9.15.3 Evolution of Business Models & Revenue Streams
    • 9.15.4 Operational Efficiency & Cost Structure Transformation
    • 9.15.5 AI-Driven Product, Service & Innovation Transformation
    • 9.15.6 Customer Behavior, AI Adoption & Future Market Evolution
    • 9.15.7 Future Outlook: AI-Led Market Evolution & Strategic Implications

  • 10.1 Benzodiazepines
    • 10.1.1 Global Insomnia Revenue Market Size and Share by Benzodiazepines 2022 - 2034
    • 10.1.2 Global Insomnia Volume Market Sales by Benzodiazepines 2022 - 2034
  • 10.2 Nonbenzodiazepines
    • 10.2.1 Global Insomnia Revenue Market Size and Share by Nonbenzodiazepines 2022 - 2034
    • 10.2.2 Global Insomnia Volume Market Sales by Nonbenzodiazepines 2022 - 2034
  • 10.3 Antidepressants
    • 10.3.1 Global Insomnia Revenue Market Size and Share by Antidepressants 2022 - 2034
    • 10.3.2 Global Insomnia Volume Market Sales by Antidepressants 2022 - 2034
  • 10.4 Orexin Antagonist
    • 10.4.1 Global Insomnia Revenue Market Size and Share by Orexin Antagonist 2022 - 2034
    • 10.4.2 Global Insomnia Volume Market Sales by Orexin Antagonist 2022 - 2034
  • 10.5 Melatonin Antagonist
    • 10.5.1 Global Insomnia Revenue Market Size and Share by Melatonin Antagonist 2022 - 2034
    • 10.5.2 Global Insomnia Volume Market Sales by Melatonin Antagonist 2022 - 2034
  • 10.6 Devices
    • 10.6.1 Global Insomnia Revenue Market Size and Share by Devices 2022 - 2034
    • 10.6.2 Global Insomnia Volume Market Sales by Devices 2022 - 2034
  • 10.7 Others
    • 10.7.1 Global Insomnia Revenue Market Size and Share by Others 2022 - 2034
    • 10.7.2 Global Insomnia Volume Market Sales by Others 2022 - 2034

  • 11.1 Hospital Pharmacies
    • 11.1.1 Global Insomnia Revenue Market Size and Share by Hospital Pharmacies 2022 - 2034
    • 11.1.2 Global Insomnia Volume Market Sales by Hospital Pharmacies 2022 - 2034
  • 11.2 Retail Pharmacies and Drug Stores
    • 11.2.1 Global Insomnia Revenue Market Size and Share by Retail Pharmacies and Drug Stores 2022 - 2034
    • 11.2.2 Global Insomnia Volume Market Sales by Retail Pharmacies and Drug Stores 2022 - 2034
  • 11.3 Online Pharmacies
    • 11.3.1 Global Insomnia Revenue Market Size and Share by Online Pharmacies 2022 - 2034
    • 11.3.2 Global Insomnia Volume Market Sales by Online Pharmacies 2022 - 2034

  • 12.1 Global Insomnia Market Export Data (2022-2025)
  • 12.2 Global Insomnia Market Import Data by Region (2022-2025)
  • 12.3 Global Insomnia Market Export Data by Region (2022-2025)
  • 12.4 North America Insomnia Market Import Data by Country (2019-2023)
  • 12.5 North America Insomnia Market Export Data by Country (2019-2023)
  • 12.6 Europe Insomnia Market Import Data by Country (2019-2023)
  • 12.7 Europe Insomnia Market Export Data by Country (2019-2023)
  • 12.8 Asia Pacific Insomnia Market Import Data by Country (2019-2023)
  • 12.9 Asia Pacific Insomnia Market Export Data by Country (2019-2023)
  • 12.10 South America Insomnia Market Import Data by Country (2019-2023)
  • 12.11 South America Insomnia Market Export Data by Country (2019-2023)
  • 12.12 Middle East and Africa Insomnia Market Import Data by Country (2019-2023)
  • 12.13 Middle East and Africa Insomnia Market Export Data by Country (2019-2023)

  • 14.1 Key Takeaways

  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    14.2 Analyst Point of View
  • 14.3 Assumptions and Acronyms

  • 15.1 Primary Data Collection
    • 15.1.1 Steps for Primary Data Collection
      • 15.1.1.1 Identification of KOL
    • 15.1.2 Backward Integration
    • 15.1.3 Forward Integration
    • 15.1.4 How Primary Research Help Us
    • 15.1.5 Modes of Primary Research
  • 15.2 Secondary Research
    • 15.2.1 How Secondary Research Help Us
    • 15.2.2 Sources of Secondary Research
  • 15.3 Data Validation
    • 15.3.1 Data Triangulation
    • 15.3.2 Top Down & Bottom Up Approach
    • 15.3.3 Cross check KOL Responses with Secondary Data
  • 15.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Insomnia Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 13+
Forecast Accuracy (Historical) 94.2%
Report Pages 250+
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about Insomnia Market

Sources from Pharma & Healthcare Industry

How We Serve You

The Three Pillars of End-to-End Market Research Services

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Insomnia Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the insomnia market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report (250+ pages)
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.